BlackRock’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616M | Buy |
|
|||||
|
2025
Q1 | $462M | Sell |
|
|||||
|
2024
Q4 | $376M | Buy |
|
|||||
|
2024
Q3 | $328M | Buy |
|
|||||
|
2024
Q2 | $315M | Buy |
|
|||||
|
2024
Q1 | $324M | Buy |
|
|||||
|
2023
Q4 | $410M | Buy |
|
|||||
|
2023
Q3 | $244M | Sell |
|
|||||
|
2023
Q2 | $165M | Buy |
|
|||||
|
2023
Q1 | $151M | Sell |
|
|||||
|
2022
Q4 | $74.4M | Buy |
|
|||||
|
2022
Q3 | $92.1M | Sell |
|
|||||
|
2022
Q2 | $85M | Buy |
|
|||||
|
2022
Q1 | $92.8M | Sell |
|
|||||
|
2021
Q4 | $155M | Sell |
|
|||||
|
2021
Q3 | $475M | Buy |
|
|||||
|
2021
Q2 | $579M | Buy |
|
|||||
|
2021
Q1 | $559M | Buy |
|
|||||
|
2020
Q4 | $463M | Buy |
|
|||||
|
2020
Q3 | $230M | Buy |
|
|||||
|
2020
Q2 | $181M | Buy |
|
|||||
|
2020
Q1 | $151M | Buy |
|
|||||
|
2019
Q4 | $93.2M | Buy |
|
|||||
|
2019
Q3 | $31.7M | Buy |
|
|||||
|
2019
Q2 | $1.44M | Buy |
|